The periovulatory and luteal phase of conception cycles following in vitro fertilization and embryo transfer. 1984

A M Dlugi, and N Laufer, and A H DeCherney, and N J MacLusky, and F P Haseltine, and M L Polan, and H C Mezer, and B Tarlatzis, and F Naftolin

The pattern of periovulatory and luteal phase levels of serum estradiol (E2) and progesterone (P) were compared between 8 conception and 28 nonconception cycles of patients undergoing in vitro fertilization (IVF). Ten additional women served as control subjects and did not undergo follicular aspiration. Follicle growth was induced with an individualized Pergonal (human menopausal gonadotropin) regimen, and laparoscopy was performed 36 hours after human chorionic gonadotropin administration. The length of the luteal phase did not differ significantly among the three groups and was between 14 and 15 days in duration. When IVF conception cycles were compared with nonconception cycles, although no difference in the number of large follicles was observed (4.25 +/- 0.45 versus 3.6 +/- 0.25), the patterns of E2 and P differed significantly. Daily serum E2 levels tended to be higher in the periovulatory phase in conception cycles when compared with nonconception cycles, and were significantly (P less than 0.05) higher in the early, mid, and late luteal phases. Serum P levels were significantly higher (P less than 0.05) in conception cycles from the midluteal phase onward. A decline in both serum E2 and P in the midluteal phase in conception cycles suggested some degree of corpus luteum deficiency. It is suggested that high E2 levels in the periovulatory phase may be an indicator of better follicular development under human menopausal gonadotropin stimulation and that the deficiency observed in the late luteal phase is overcome with the establishment of pregnancy.

UI MeSH Term Description Entries
D008596 Menotropins Extracts of urine from menopausal women that contain high concentrations of pituitary gonadotropins, FOLLICLE STIMULATING HORMONE and LUTEINIZING HORMONE. Menotropins are used to treat infertility. The FSH:LH ratio and degree of purity vary in different preparations. Gonadotropins, Human Menopausal,Human Menopausal Gonadotropin,CP-89044,CP-90033,HMG Ferring,HMG Lepori,HMG Massone,Humegon,Menogon,Menopur,Menotrophin,Normegon,ORG-31338,Pergonal,Pergonal-500,CP 89044,CP 90033,CP89044,CP90033,Gonadotropin, Human Menopausal,Human Menopausal Gonadotropins,Lepori, HMG,Menopausal Gonadotropin, Human,ORG 31338,ORG31338,Pergonal 500,Pergonal500
D010060 Ovulation The discharge of an OVUM from a rupturing follicle in the OVARY. Ovulations
D010062 Ovulation Induction Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum. Ovarian Stimulation,Ovarian Stimulations,Stimulation, Ovarian,Stimulations, Ovarian
D010535 Laparoscopy A procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy. Celioscopy,Laparoscopic Surgical Procedures,Peritoneoscopy,Surgical Procedures, Laparoscopic,Laparoscopic Assisted Surgery,Laparoscopic Surgery,Laparoscopic Surgical Procedure,Procedure, Laparoscopic Surgical,Procedures, Laparoscopic Surgical,Surgery, Laparoscopic,Surgical Procedure, Laparoscopic,Celioscopies,Laparoscopic Assisted Surgeries,Laparoscopic Surgeries,Laparoscopies,Peritoneoscopies,Surgeries, Laparoscopic,Surgeries, Laparoscopic Assisted,Surgery, Laparoscopic Assisted
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003338 Corpus Luteum The yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE. Corpora Lutea,Lutea, Corpora
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004624 Embryo Transfer The transfer of mammalian embryos from an in vivo or in vitro environment to a suitable host to improve pregnancy or gestational outcome in human or animal. In human fertility treatment programs, preimplantation embryos ranging from the 4-cell stage to the blastocyst stage are transferred to the uterine cavity between 3-5 days after FERTILIZATION IN VITRO. Blastocyst Transfer,Tubal Embryo Transfer,Tubal Embryo Stage Transfer,Embryo Transfers,Transfer, Embryo,Transfers, Embryo
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females

Related Publications

A M Dlugi, and N Laufer, and A H DeCherney, and N J MacLusky, and F P Haseltine, and M L Polan, and H C Mezer, and B Tarlatzis, and F Naftolin
January 1982, Archives of gynecology,
A M Dlugi, and N Laufer, and A H DeCherney, and N J MacLusky, and F P Haseltine, and M L Polan, and H C Mezer, and B Tarlatzis, and F Naftolin
December 2004, Ginecologia y obstetricia de Mexico,
A M Dlugi, and N Laufer, and A H DeCherney, and N J MacLusky, and F P Haseltine, and M L Polan, and H C Mezer, and B Tarlatzis, and F Naftolin
January 1991, Fertility and sterility,
A M Dlugi, and N Laufer, and A H DeCherney, and N J MacLusky, and F P Haseltine, and M L Polan, and H C Mezer, and B Tarlatzis, and F Naftolin
January 1986, Fertility and sterility,
A M Dlugi, and N Laufer, and A H DeCherney, and N J MacLusky, and F P Haseltine, and M L Polan, and H C Mezer, and B Tarlatzis, and F Naftolin
September 1986, Fertility and sterility,
A M Dlugi, and N Laufer, and A H DeCherney, and N J MacLusky, and F P Haseltine, and M L Polan, and H C Mezer, and B Tarlatzis, and F Naftolin
March 1990, Fertility and sterility,
A M Dlugi, and N Laufer, and A H DeCherney, and N J MacLusky, and F P Haseltine, and M L Polan, and H C Mezer, and B Tarlatzis, and F Naftolin
May 1983, Geburtshilfe und Frauenheilkunde,
A M Dlugi, and N Laufer, and A H DeCherney, and N J MacLusky, and F P Haseltine, and M L Polan, and H C Mezer, and B Tarlatzis, and F Naftolin
June 1990, Journal of in vitro fertilization and embryo transfer : IVF,
A M Dlugi, and N Laufer, and A H DeCherney, and N J MacLusky, and F P Haseltine, and M L Polan, and H C Mezer, and B Tarlatzis, and F Naftolin
April 2000, Fertility and sterility,
A M Dlugi, and N Laufer, and A H DeCherney, and N J MacLusky, and F P Haseltine, and M L Polan, and H C Mezer, and B Tarlatzis, and F Naftolin
April 1988, Journal of in vitro fertilization and embryo transfer : IVF,
Copied contents to your clipboard!